AOK PLUS - DIE GESUNDHEITSKASSE FÜR SACHSEN UND THÜRINGEN has floated a tender for Contract notice: Pharmaceutical products. The project location is Germany and the tender is closing on 30 Sep 2019. The tender notice number is 281975-2017, while the TOT Ref Number is 15035374. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Expired Tender

Procurement Summary

Country : Germany

Summary : Contract notice: Pharmaceutical products

Deadline : 30 Sep 2019

Other Information

Notice Type : Tender

TOT Ref.No.: 15035374

Document Ref. No. : 281975-2017

Competition : ICB

Financier : Self Financed

Purchaser Ownership : -

Tender Value : Refer Document

Purchaser's Detail

Purchaser : AOK PLUS - DIE GESUNDHEITSKASSE FÜR SACHSEN UND THÜRINGEN
Office Name: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen
Address: Augustinerstraße 38
Town: Erfurt
Postal Code: 99084
Contact Point: Unternehmensbereich Corporate Governance, Geschäftsbereich Zentrale Vergabestelle
Attention: Herrn Rechtsanwalt Sören Rabe


Germany
Email :vergabestelle@plus.aok.de
URL :https://plus.aok.de

Tender Details

Object of the contract
Pharmaceutical products

Description: Contract notice: Pharmaceutical products

Authority Type: Body governed by public law
Contact Nature: Supplies
Procedure: Open procedure
Document: Contract notice
Regulation: European Union, with participation by GPA countries
Award criteria: Not specified
CPV code: 33600000, 33600000
CPV Description: Conclusion of non-exclusive discount agreements pursuant to section 130a para. 8 SGB V with the possibility to close at any time within the scope of an open-house model within the period from 16.8.2017 to 30.9.2019 for medicaments for the drug combination dienogest / ethinyl estradiol (ATC code According to WHO: G03AA16).

Pharmaceutical products.

The object of this publication is to conclude discount agreements(ATC code according to WHO: G03AA16) within the framework of an "open-house model". All pharmaceutical companies which are interested and suitable are selected on the basis of uniform conditions as well as a The access to a discount agreement pursuant to Article 130a (8)SGB V offered. An exclusivity is not given. At the time of the conclusion of the agreement, the amount of waste is unknown, and in particular depends on the demand of the insured persons, the development of the number of insured persons, the regulation behavior of the contracting parties and the dispensing and stockholding behavior of the public pharmacies. The client does not guarantee minimum acceptance quantitiesThe agreement may be concluded at any time and under the same conditions. No specific contract negotiations will be carried out.

Interested pharmaceutical companies may request the participation documents (discount agreement and the form mentioned under III.2.1) via the e-mail address given under I.1)-From 16.8.2017 to 30.9.2019 closed. Interested parties are required to submit the fully completed and signed participation documents (declaration of non-existence of exclusions and discount agreement) to 15.8.2017 for the first time and then to the 15th of a month at the address mentioned under I.1). Access to the AOK PLUS is available. If the 15th of a month falls aOn a Saturday, Sunday or nationwide public holiday, the next working day shall be replaced by such day. The discount agreement enters into force by signing the AOK PLUS. The signing will take place until the end of the month in which the attendance documents have been received by AOK PLUS. In case of later receipt (after 15.8.2017 or after the 15th of a month)The participation documents submitted will be considered for the 15th of the following month.

Participation documents may be submitted for the first time on 15.8.2017.

A pre-run of approximately half a month by the AOK PLUS is necessary to carry out the declarations of the discount agreement. The initial labeling of the discount medicines in the pharmacy software takes place from dem second month following the deadline for receipt of entry forms. When changes or realignments of time limits for the date messages in the nationwide AOK contract reporting portal DatRabatt this time may vary.

With all pharmaceutical companies that meet the eligibility requirements and confirm this by their signature to the requested documents, wiA contract agreement is concluded.

The contract ends on 30.9.2019 at the latest, irrespective of the date of conclusion of the contract. The AOK PLUS The health insurance fund for Saxony and Thueringen has the right to replace the non-exclusive open-house discount agreements by exclusive discount agreements during the term of the agreement. With the entry into force, Iver discount agreements automatically terminate the open-house agreements. The present open-house procedure is terminated in this case. According to the experience of the AOK PLUS, exclusive rebate agreements come into force usually eight to twelve months after the publication of the corresponding notice notice in the Supplement to the Official Journal of the European Union. The future(Note: this contract is not a public procurement contract within the meaning of the Guidelines for the award of contracts (2014/24 / EC) EU) or of the right to be granted. In order to achieve the widest degree of transparency for theThe contract shall be published in the Supplement to the Official Journal of the European Union. In the absence of a corresponding publication form, the contract notice shall be used. The resulting conceptual specifications, such as, for example, the procedure description "open procedure", are solely for the use of this publication form and-Of the publishing platform. A further meaning, in particular a submission under the rules of the law, to the extent that they are not compulsory for legal reasons, is not connected with this
Internet address (URL): https://plus.aok.de
Directive: Classical Directive (2004/18/EC)

Documents

 Tender Notice